This opportunity is currently closed.

Sign up for Content alerts to stay informed when this or related funding opportunities are posted.


Clinical Trial Awards Program (ALS research worldwide)


The Clinical Trial Awards (CTA) Program funded by the ALS Association offers funding for investigators in industry or academia worldwide. This funding is for researchers focused on clinically testing novel or repositioning approaches for Amyotrophic Lateral Sclerosis (ALS).

This funding provides up to $1,000,000 USD total costs to be allocated over two or three years, with indirect costs limited to 10%.

  • Budgets for direct and indirect costs up to $1,000,000 USD:
    • 2-year project – First year: $500,000; Second year: $500,000
    • 3-year project – First year: $500,000; Second year: $250,000; Third year: $250,000

This year, a letter of intent is due on May 17, 2023. Full applications are by invitation only and due on August 2, 2023.

Register for free

Don´t have an account?

Start with our free trial to enjoy our 7 days of unlimited grant access and our premium features.

or, Choose a plan to subscribe to our premium membership.

Be the first to know

Sign-up for Personalized Grant alerts


Sign-up for our
monthly research
funding newsletter

You can unsubscribe at any time.